Search Results Search Sort by RelevanceMost Recent Medicine and Society May 2019 How Should Mechanical Circulatory Support Be Deactivated for Patients With Depression at the End of Life? Stephan R. Weinland, PhD, MS and James Levenson, MD End-stage heart failure patients can experience depression along with their chronic illness. Multidisciplinary responses are critical. AMA J Ethics. 2019;21(5):E429-434. doi: 10.1001/amajethics.2019.429. Letter to the Editor Oct 2019 Response to “Will We Code for Default ECMO?”: Clarifying the Scope of Do-Not-ECMO Orders Jacob A. Blythe, MA, Sarah E. Wieten, PhD, and Jason N. Batten, MD, MA The authors further consider the merits of preventing ECMO from becoming a default treatment. AMA J Ethics. 2019;21(10):E926-929. doi: 10.1001/amajethics.2019.926. Medicine and Society Oct 2010 The Personal, Social, and Economic Determinants of Cardiovascular Disease Jane S. Jue, MD, MSc Virtual Mentor. 2010;12(10):812-817. doi: 10.1001/virtualmentor.2010.12.10.msoc1-1010. Medicine and Society Oct 2010 “For Me There Is No Substitute”: Authenticity, Uniqueness, and the Lessons of Lipitor Jeremy A. Greene, MD, PhD The phrase “I take Lipitor instead of a generic” was embedded in the public consciousness through an advertising campaign that featured Robert Jarvik, credited with the invention of the artificial heart. Virtual Mentor. 2010;12(10):818-823. doi: 10.1001/virtualmentor.2010.12.10.msoc2-1010.